Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 11/2 years.BackgroundPrevious studies reported a significant association between hyperlipidemia of the recipient and chronic allograft nephropathy (CAN). However, the nature and the pathogenic mechanism of circulating lipid abnormalities in CAN remain unclear.MethodsIn a prospective study of 50 consecutive adult recipients of a cadaveric renal allograft, we investigated the impact of lipid abnormalities on the outcome of the graft at 11/2 years. Besides morphometric analysis of implantation and protocol biopsies, clinical and biochemical variables were studied at three-month intervals. Plasma concentrations of oxidized low-density lipoprotein (OxLDL) w...
Background: In kidney transplantation, the prevalence of hypercholesterolemia as a co-morbidity fact...
7; a Dyslipidemia is an important complication of kidney showing that serum cholesterol levels have ...
Background: Protection of low-density lipoproteins (LDL) against oxidative modification is a key ant...
Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 11/2 years...
Role of circulating lipid abnormalities in chronic renal allograft rejection. The evidence that circ...
Increased low density lipoprotein oxidation in stable kidney transplant recipients. We studied facto...
Background: Renal transplantation is increasingly associated with the presence of comorbidity factor...
Background: Renal transplantation is increasingly associated with the presence of comorbidity factor...
Hyperlipidemia: A risk factor for chronic allograft dysfunction. While the early results of renal tr...
Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients....
AbstractBackgroundProtection of low-density lipoproteins (LDL) against oxidative modification is a k...
Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant...
Role of circulating lipid abnormalities in chronic renal allograft rejection. The evidence that circ...
Oxidation of low density lipoproteins from patients with renal failure or a renal transplant. Peroxi...
In this study, the graft outcome in renal allograft recipients with [high cholesterol group (HCG), n...
Background: In kidney transplantation, the prevalence of hypercholesterolemia as a co-morbidity fact...
7; a Dyslipidemia is an important complication of kidney showing that serum cholesterol levels have ...
Background: Protection of low-density lipoproteins (LDL) against oxidative modification is a key ant...
Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 11/2 years...
Role of circulating lipid abnormalities in chronic renal allograft rejection. The evidence that circ...
Increased low density lipoprotein oxidation in stable kidney transplant recipients. We studied facto...
Background: Renal transplantation is increasingly associated with the presence of comorbidity factor...
Background: Renal transplantation is increasingly associated with the presence of comorbidity factor...
Hyperlipidemia: A risk factor for chronic allograft dysfunction. While the early results of renal tr...
Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients....
AbstractBackgroundProtection of low-density lipoproteins (LDL) against oxidative modification is a k...
Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant...
Role of circulating lipid abnormalities in chronic renal allograft rejection. The evidence that circ...
Oxidation of low density lipoproteins from patients with renal failure or a renal transplant. Peroxi...
In this study, the graft outcome in renal allograft recipients with [high cholesterol group (HCG), n...
Background: In kidney transplantation, the prevalence of hypercholesterolemia as a co-morbidity fact...
7; a Dyslipidemia is an important complication of kidney showing that serum cholesterol levels have ...
Background: Protection of low-density lipoproteins (LDL) against oxidative modification is a key ant...